Kai Hideaki

MISC (5)：

Marcello Rossi, Hideaki Kai, Simone Baiardi, Anna Bartoletti-Stella, Benedetta Carlà, Corrado Zenesini, Sabina Capellari, Tetsuyuki Kitamoto, Piero Parchi. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins. Acta neuropathologica communications. 2019. 7. 53
Aiko Ishiki, Ryuichi Harada, Hideaki Kai, Naomi Sato, Tomoko Totsune, Naoki Tomita, Shoichi Watanuki, Kotaro Hiraoka, Yoichi Ishikawa, Yoshihito Funaki, et al. Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy. Acta neuropathologica communications. 2018. 6. 1. 53-53
Ryuichi Harada, Aiko Ishiki, Hideaki Kai, Naomi Sato, Katsutoshi Furukawa, Shozo Furumoto, Tetsuro Tago, Naoki Tomita, Shoichi Watanuki, Kotaro Hiraoka, et al. Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2018. 59. 4. 671-674
Francesca Lattanzio, Samir Abu-Rumeileh, Alessia Franceschini, Hideaki Kai, Giulia Amore, Ilaria Poggiolini, Marcello Rossi, Simone Baiardi, Lynne McGuire, Anna Ladogana, et al. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A beta 42 levels. ACTA NEUROPATHOLOGICA. 2017. 133. 4. 559-578
Hideaki Kai, Ryong-Woon Shin, Koichi Ogino, Hiroyuki Hatsuta, Shigeo Murayama, Tetsuyuki Kitamoto. Enhanced Antigen Retrieval of Amyloid beta Immunohistochemistry: Re-evaluation of Amyloid beta Pathology in Alzheimer Disease and Its Mouse Model. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 2012. 60. 10. 761-769

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page